YARW

Yarrow Bioscience, Inc. Common Stock

26.26

USD

-0.75

-2.78%

Sep 14, 15:59 UTC -4

Closed

After-Market

26.87

+0.61

+2.31%

Yarrow Bioscience, Inc. Common Stock Profile

About

Yarrow Bioscience Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The Company is developing YB-101, a potentially first-in-class anti-thyroid stimulating hormone receptor monoclonal antibody designed to directly and rapidly disrupt the central mechanism of both GD and TED. Yarrow Bioscience Inc., formerly known as VYNE Therapeutics Inc., is based in NEW HAVEN, Conn.

Info & Links

CEO

David Domzalski

Headquarters

685 ROUTE 202/206, SUITE 301
BRIDGEWATER, NJ 08807, UNITED STATES

Auditor

Baker Tilly US, LLP

Share holders

Employees

Yarrow Bioscience, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

71.73M

Enterprise Value

48.80M

Enterprise Value/EBITDA(ttm)

-2.42

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

158.83

Price to Book(mrq)

0.82

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

-4783.70%

Profit Margin(ttm)

-3824.27%

Return on Equity(ttm)

-84.40%

Return on Invested Capital(ttm)

-68.70%

Return on Assets(ttm)

-77.68%

Income Statement

Revenue(ttm)

482.00K

Revenue Per Share(ttm)

0.18

Gross Profit(ttm)

482.00K

EBITDA(ttm)³

-20.17M

Net Income Available to Common(ttm)

-18.71M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

2.01

52-Week Change

S&P 500 52-Week Change

18.15%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

2.67M

Dividend Yield

0.00%

Float⁴

2.59M

% Held by Insiders

3.03%

% Held by Institutions

83.78%

Balance Sheet

Total Cash(mrq)

22.93M

Total Cash Per Share(mrq)

8.59

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.26%

Quick Ratio(mrq)

15.26%

Book Value Per Share(mrq)

33.03

Cash Flow

Operating Cash Flow Per Share(ytd)

-7.08

Free Cash Flow(ytd)

-6.07M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.